Dengue hepatitis: Incidence, spectrum and outcome.
Acute liver failure
Dengue
Dengue hemorrhagic fever
Dengue hepatitis
Ferritin
Hemophagocytosis
Lactate dehydrogenase
Mortality
Prognostic markers
Severe dengue
Journal
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology
ISSN: 0975-0711
Titre abrégé: Indian J Gastroenterol
Pays: India
ID NLM: 8409436
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
15
11
2021
accepted:
22
05
2023
medline:
19
7
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
ppublish
Résumé
While dengue infection is common in India, there is scarce information on dengue hepatitis. The aim of this study was to analyze the incidence, spectrum and outcome of dengue hepatitis. We retrospectively analyzed consecutive patients, who had hepatitis among those with dengue infection admitted to two tertiary care hospitals in western India from January 2016 to March 2021. Diagnosis of dengue infection was made by serology. Dengue hepatitis was diagnosed and the severity of dengue was categorized by standard criteria. Of 1664 patients admitted with dengue fever during the study period, 199 patients had hepatitis (i.e. incidence of dengue hepatitis was 11.9%). Of the 199 dengue hepatitis patients (age: 29 [13 - 80] years, median [range], 67% males), 100 patients (50%) had severe dengue, 73 (36%) had severe dengue hepatitis, 32 (16%) had dengue shock syndrome and eight (4%) had acute liver failure. Forty-five patients (23%) had acute lung injury and 32 (16%) had acute kidney injury. The dengue hepatitis patients were treated with standard medical care, including vital organ support, as needed-166 (83%) patients survived, while 33 patients (17%) died (cause of death: multi-organ failure: 24 patients, septic shock: nine patients). The presence of shock independently predicted mortality (odds ratio 6.4, 95% confidence interval: 1.2 - 34). Among patients with dengue hepatitis, mortality rate was higher in those with severe dengue (23%), dengue shock syndrome (47%), severe dengue hepatitis (24%) and acute liver failure (38%). In this large series of hospitalized patients with dengue infection, the incidence of dengue hepatitis was 11.9%. Among 199 dengue hepatitis, 17% died; multi-organ failure was the commonest cause for death and death rate was higher in patients with more severe disease. The presence of shock at presentation independently predicted mortality.
Sections du résumé
BACKGROUND AND AIMS
While dengue infection is common in India, there is scarce information on dengue hepatitis. The aim of this study was to analyze the incidence, spectrum and outcome of dengue hepatitis.
METHODS
We retrospectively analyzed consecutive patients, who had hepatitis among those with dengue infection admitted to two tertiary care hospitals in western India from January 2016 to March 2021. Diagnosis of dengue infection was made by serology. Dengue hepatitis was diagnosed and the severity of dengue was categorized by standard criteria.
RESULTS
Of 1664 patients admitted with dengue fever during the study period, 199 patients had hepatitis (i.e. incidence of dengue hepatitis was 11.9%). Of the 199 dengue hepatitis patients (age: 29 [13 - 80] years, median [range], 67% males), 100 patients (50%) had severe dengue, 73 (36%) had severe dengue hepatitis, 32 (16%) had dengue shock syndrome and eight (4%) had acute liver failure. Forty-five patients (23%) had acute lung injury and 32 (16%) had acute kidney injury. The dengue hepatitis patients were treated with standard medical care, including vital organ support, as needed-166 (83%) patients survived, while 33 patients (17%) died (cause of death: multi-organ failure: 24 patients, septic shock: nine patients). The presence of shock independently predicted mortality (odds ratio 6.4, 95% confidence interval: 1.2 - 34). Among patients with dengue hepatitis, mortality rate was higher in those with severe dengue (23%), dengue shock syndrome (47%), severe dengue hepatitis (24%) and acute liver failure (38%).
CONCLUSION
In this large series of hospitalized patients with dengue infection, the incidence of dengue hepatitis was 11.9%. Among 199 dengue hepatitis, 17% died; multi-organ failure was the commonest cause for death and death rate was higher in patients with more severe disease. The presence of shock at presentation independently predicted mortality.
Identifiants
pubmed: 37335522
doi: 10.1007/s12664-023-01405-0
pii: 10.1007/s12664-023-01405-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
355-360Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023. Indian Society of Gastroenterology.
Références
Souza LJ de, Alves JG, Nogueira RMR, et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz J Infect Dis. 2004;8:156–63.
Kumar A, Arora A. Non-viral infective and non-infective nimics of hepatitis. In: Anand AC, ed. Viral Hepatitis in Indian Subcontinent. . 1st ed. Indian College of Physicians, Mumbai: India; 2017. pp. 91–118.
Kumar A, Arora A. Liver involvement in common febrile illnesses. Curr Med Res Pract. 2018;8:170–6.
doi: 10.1016/j.cmrp.2018.08.001
Kulkarni AV, Choudhury AK, Premkumar M, Jain P, Gupta E, Sarin SK. Spectrum, manifestations and outcomes of dengue infection in individuals with and without liver disease. J Clin Transl Hepatol. 2019;7:106–11.
Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition [Internet]. Geneva: World Health Organization; 2009. Available from: http://www.ncbi.nlm.nih.gov/books/NBK143157/ . Accessed 30 November 2022
O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342:273–5.
Devarbhavi H, Ganga D, Menon M, Kothari K, Singh R. Dengue hepatitis with acute liver failure: Clinical, biochemical, histopathological characteristics and predictors of outcome. J Gastroenterol Hepatol. 2020;35:1223–8.
doi: 10.1111/jgh.14927
pubmed: 31749188
Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue fever. Am J Trop Med Hyg. 1992;47:265–70.
doi: 10.4269/ajtmh.1992.47.265
pubmed: 1355950
Nath P, Agrawal DK, Mehrotra RM. Ultrastructural changes in skeletal muscles in dengue virus-infected mice. J Pathol. 1982;136:301–5.
doi: 10.1002/path.1711360405
pubmed: 7077434
Kalita J, Misra UK, Mahadevan A, Shankar SK. Acute pure motor quadriplegia: is it dengue myositis? Electromyogr Clin Neurophysiol. 2005;45:357–61.
pubmed: 16315973
Seneviratne SL, Malavige GN, de Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg. 2006;100:608–14.
doi: 10.1016/j.trstmh.2005.10.007
pubmed: 16483623
Lee LK, Gan VC, Lee VJ, Tan AS, Leo YS, Lye DC. Clinical relevance and discriminatory value of elevated liver aminotransferase levels for dengue severity. PLoS Negl Trop Dis. 2012;6: e1676.
doi: 10.1371/journal.pntd.0001676
pubmed: 22679523
pmcid: 3367991
Chongsrisawat V, Hutagalung Y, Poovorawan Y. Liver function test results and outcomes in children with acute liver failure due to dengue infection. Southeast Asian J Trop Med Public Health. 2009;40:47–53.
pubmed: 19323033
Deepak NA, Patel ND. Differential diagnosis of acute liver failure in India. Ann Hepatol. 2006;5:150–6.
doi: 10.1016/S1665-2681(19)31998-2
Tan S-S, Bujang MA. The clinical features and outcomes of acute liver failure associated with dengue infection in adults: a case series. Braz J Infect Dis. 2013;17:164–9.
Bhushan D, Kumar R. Clinical profile, hepatic dysfunctions, and outcome of dengue patients in a tertiary care hospital of eastern India. J Assoc Physicians India. 2018;66:52–4.
Sangkaew S, Ming D, Boonyasiri A, et al. Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21:1014–26.
Fahmy M, Young SP. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem J. 1993;296 Pt 1:175–81.
Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood. 2003;101:4148–54.
doi: 10.1182/blood-2002-08-2459
pubmed: 12522003
Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood. 1997;90:4979–86.
doi: 10.1182/blood.V90.12.4979
pubmed: 9389717
Petchiappan V, Hussain TM, Thangavelu S. Can serum ferritin levels predict the severity of dengue early?: an observational study. Int J Res Med Sci. 2019;7:876–81.
doi: 10.18203/2320-6012.ijrms20190940
Suresh SC, Hanumanthaiah R, Ramakrishna C, et al. Serum ferritin as a prognostic indicator in adult dengue patients. Am J Trop Med Hyg. 2021;104:1072–8.
Soundravally R, Agieshkumar B, Daisy M, Sherin J, Cleetus CC. Ferritin levels predict severe dengue. Infection. 2015;43:13–9.
doi: 10.1007/s15010-014-0683-4
pubmed: 25354733
Goel R, Eapen CE. Recognizing dysfunctional innate and adaptive immune responses contributing to liver damage in patients with cirrhosis. J Clin Exp Hepatol. 2022;12:993–1002.
De Koninck A-S, Dierick J, Steyaert S, Taelman P. Hemophagocytic lymphohistiocytosis and dengue infection: rare case report. Acta Clin Belg. 2014;69:210–3.
doi: 10.1179/2295333714Y.0000000019
pubmed: 24820925
Yoshifuji K, Oshina T, Sonokawa S, et al. Domestic dengue infection with hemophagocytic lymphohistiocytosis successfully treated by early steroid therapy. Rinsho Ketsueki. 2016;57:864–8.
Eapen CE, Nair SC. Potential danger of isolated platelet transfusion in patients with dengue infection. Indian J Med Res. 2017;145:158–60.
pubmed: 28639589
pmcid: 5501045
Zachariah U, Kumar SE, Alexander V, Patel L, Goel A, Eapen CE. Low-volume plasma exchange and low-dose steroid to treat severe liver injury. Gastroenterol Hepatol Endosc Pract. 2021;1:47–54.
Alexander V, Zachariah U, Goel A, et al. Low-volume plasma exchange and low-dose steroid to treat secondary hemophagocytic lymphohistiocytosis: A potential treatment for severe COVID-19? Curr Med Issues. 2020;18:77–82.